Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, April 17, 2023
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
Laura Chico Maintained (TVTX) at Buy with Decreased Target to $29 on, Apr 17th, 2023
Laura Chico of Wedbush, Maintained "Travere Therapeutics, Inc." (TVTX) at Buy with Decreased Target from $30 to $29 on, Apr 17th, 2023.
Laura has made no other calls on TVTX in the last 4 months.
There are 5 other peers that have a rating on TVTX. Out of the 5 peers that are also analyzing TVTX, 0 agree with Laura's Rating of Hold.
These are the ratings of the 5 analyists that currently disagree with Laura
- Vamil Divan of "Guggenheim" Initiated at Strong Buy and Held Target at $37 on, Wednesday, March 1st, 2023
- Edward Nash of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $42 on, Tuesday, February 28th, 2023
- Ed Arce of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $40 on, Friday, February 24th, 2023
- Carter Gould of "Barclays" Maintained at Buy with Decreased Target to $31 on, Tuesday, February 21st, 2023
- Do Kim of "Piper Sandler" Maintained at Buy with Increased Target to $46 on, Tuesday, February 21st, 2023
